FFA
CPRX

Farther Finance Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

Farther Finance Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6K Sell
1,070
-673
-39% -$19.9K ﹤0.01% 3569
2026
Q1 		$43.3K Buy
1,743
+199
+13% +$4.74K ﹤0.01% 3091
2025
Q4 		$36K Sell
1,544
-97
-6% -$2.16K ﹤0.01% 3022
2025
Q3 		$32.3K Buy
1,641
+119
+8% +$2.45K ﹤0.01% 2721
2025
Q2 		$33K Sell
1,522
-142
-9% -$3.35K ﹤0.01% 2357
2025
Q1 		$39.8K Sell
1,664
-1,026
-38% -$23.1K ﹤0.01% 2009
2024
Q4 		$56.1K Buy
2,690
+1,495
+125% +$32.1K ﹤0.01% 1600
2024
Q3 		$23.8K Buy
1,195
+713
+148% +$13.2K ﹤0.01% 2004
2024
Q2 		$7.6K Buy
482
+70
+17% +$1.09K ﹤0.01% 2188
2024
Q1 		$6.49K Buy
412
+9
+2% +$136 ﹤0.01% 1947
2023
Q4 		$6.77K Sell
403
-165
-29% -$2.25K ﹤0.01% 1816
2023
Q3 		$6.64K Hold
568
– – ﹤0.01% 1422
2023
Q2 		$7.63K Hold
568
– – ﹤0.01% 1281
2023
Q1 		$9.42K Hold
568
– – ﹤0.01% 1137
2022
Q4 		$10.6K Buy
+568
New +$8.74K ﹤0.01% 929

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Farther Finance Advisors's CPRX Position: Q2 2026 in Review

Farther Finance Advisors reduced its Catalyst Pharmaceutical (CPRX) stake by 39% in Q2 2026, selling an estimated $19.9K and leaving 1,070 shares worth $33.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Farther Finance Advisors first reported a position in CPRX in Q4 2022 and has held it in 15 quarters since. The position peaked at $56.1K in Q4 2024. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Farther Finance Advisors held 1,070 shares of Catalyst Pharmaceutical worth $33.6K as of Q2 2026.
  • Farther Finance Advisors sold 673 Catalyst Pharmaceutical shares in Q2 2026, an estimated $19.9K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3569 holding.
  • Farther Finance Advisors first reported a position in Catalyst Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Catalyst Pharmaceutical position peaked at $56.1K in Q4 2024.
  • 36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.